• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    0.40 Down 0.02(4.99%) Apr 29, 4:00PM EDT
    |After Hours : 0.40 0.00 (0.00%) Apr 29, 4:00PM EDT
    Prev Close:0.42
    Open:0.42
    Bid:0.38 x 100
    Ask:0.49 x 100
    1y Target Est:1.00
    Beta:0.875801
    Next Earnings Date:N/A
    Day's Range:0.39 - 0.44
    52wk Range:0.15 - 2.65
    Volume:937,734
    Avg Vol (3m):1,350,780
    Market Cap:54.96M
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNTA

    Comparison

    Symbol% ChgMkt Cap
    SNTADown 4.99%54.96M
    INFIDown 2.85%286.47M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.07
    Quarterly EPS Est (Mar-16) :-0.03
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synta Pharmaceuticals Corp. focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its clinical stage drug candidate in oncology is ganetespib, an Hsp90 inhibitor, which is in Phase II clinical... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback